ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 35 filers reported holding ASLAN PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $170,000 | -22.4% | 343,720 | +41.0% | 0.05% | -19.3% |
| Q1 2022 | $219,000 | -73.3% | 243,720 | -66.7% | 0.06% | -72.3% |
| Q4 2021 | $820,000 | -37.1% | 732,500 | 0.0% | 0.21% | -40.5% |
| Q3 2021 | $1,304,000 | -41.7% | 732,500 | +8.1% | 0.35% | -26.1% |
| Q2 2021 | $2,236,000 | -1.5% | 677,500 | 0.0% | 0.47% | -13.2% |
| Q1 2021 | $2,270,000 | +1284.1% | 677,500 | +687.0% | 0.54% | +917.0% |
| Q3 2020 | $164,000 | -4.7% | 86,082 | 0.0% | 0.05% | +6.0% |
| Q2 2020 | $172,000 | +95.5% | 86,082 | 0.0% | 0.05% | +35.1% |
| Q1 2020 | $88,000 | -63.2% | 86,082 | -26.9% | 0.04% | -54.9% |
| Q4 2019 | $239,000 | – | 117,682 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,194,070 | $3,940,000 | 2.71% |
| Sio Capital Management, LLC | 1,488,508 | $4,912,000 | 1.22% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $8,298,000 | 0.85% |
| KNOTT DAVID M | 478,186 | $1,578,000 | 0.56% |
| Logos Global Management LP | 2,000,000 | $6,600,000 | 0.56% |
| DAFNA Capital Management LLC | 677,500 | $2,236,000 | 0.47% |
| Vivo Capital, LLC | 2,840,909 | $9,375,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 765,276 | $2,525,000 | 0.36% |
| MYDA Advisors LLC | 211,165 | $697,000 | 0.17% |
| Parkman Healthcare Partners LLC | 225,881 | $745,000 | 0.16% |